How should I manage a patient who presents with chest pain and a herpes zoster rash on the chest?

Management of Chest Pain with Herpes Zoster Rash

You must first rule out life-threatening cardiac causes of chest pain before attributing symptoms solely to herpes zoster, even when a dermatomal rash is present. 1

Initial Evaluation Priority

The 2021 AHA/ACC/CHEST guideline explicitly states that a focused cardiovascular examination must be performed initially to aid in diagnosis of acute coronary syndrome (ACS) or other potentially serious causes of chest pain (Class I recommendation). 1 While herpes zoster produces a painful rash in a dermatomal distribution, the guideline emphasizes that the initial evaluation should focus on life-threatening causes including ACS, pulmonary embolism, aortic dissection, and esophageal rupture. 1

Critical Assessment Steps:

Perform immediately:

• ECG within 10 minutes unless a noncardiac cause is definitively evident 1
• High-sensitivity cardiac troponins - these are the preferred standard for establishing or excluding myocardial injury 1
• Focused cardiovascular exam looking for: diaphoresis, tachypnea, tachycardia, hypotension, crackles, S3 gallop, or new murmurs 1

Key clinical distinction: With uncomplicated acute myocardial infarction, the physical examination may be completely normal. 1 Do not be falsely reassured by the presence of a zoster rash.

Risk Stratification

Use structured risk assessment protocols to determine if the patient is low, intermediate, or high risk for obstructive coronary artery disease. 1

• Low-risk patients: Urgent diagnostic testing for suspected CAD is not needed 1
• Intermediate to high-risk patients: Will benefit most from cardiac imaging and testing 1

Herpes Zoster-Specific Considerations

Once cardiac causes are adequately excluded or addressed:

Recognize Rare but Serious VZV Cardiac Complications

Be aware that varicella zoster virus can cause pericarditis and pericardial effusion, though this is uncommon. 2, 3 VZV-associated pericardial effusion should be considered particularly when the dermatomal rash affects the C3-C5 and T1-T4 distributions (chest dermatomes). 2 There are documented cases of VZV causing cardiac tamponade, though extremely rare. 2

Clinical clue: If chest pain is pleuritic, increases in the supine position, or if you detect a friction rub on examination, consider pericarditis as a potential complication of the zoster infection itself. 1

Antiviral Treatment

Initiate high-dose IV acyclovir for immunocompromised patients with herpes zoster. 4 For immunocompetent patients, oral antivirals (acyclovir, famciclovir, or valacyclovir) should be started within 72 hours of rash onset to reduce severity, duration, and intensity of pain. 5, 6

Dosing considerations:

• IV acyclovir remains the treatment of choice for VZV infections in compromised hosts 4
• Oral therapy is appropriate for immunocompetent patients or to complete therapy after clinical response to IV treatment 4

Pain Management

For acute zoster-associated pain:

• Opioid analgesics for severe acute pain 6
• Consider early initiation of tricyclic antidepressants or anticonvulsants (gabapentin, pregabalin) in patients at high risk for postherpetic neuralgia 5, 6
• NSAIDs like aspirin for mild to moderate pain 3

High-risk features for postherpetic neuralgia include:

• Advanced age (>60 years)
• Severe acute pain
• Extensive rash
• Immunocompromised status 5, 7

Common Pitfalls to Avoid

1. Do not assume chest pain is "just the zoster" without cardiac workup - the examination may be normal even with acute MI 1

2. Do not delay antiviral therapy while pursuing cardiac evaluation - these can proceed simultaneously, and antivirals are most effective when started within 72 hours 5, 6

3. Do not miss disseminated VZV in immunocompromised patients - without prompt antiviral therapy, 10-20% risk dissemination 4

4. Consider antiviral resistance if lesions develop in patients already taking prophylactic acyclovir or valacyclovir 4

Clinical Algorithm

1. Immediate: ECG + high-sensitivity troponin + focused cardiovascular exam
2. If cardiac risk factors or abnormal findings: Proceed with ACS protocol per institutional guidelines
3. Once cardiac causes excluded/addressed: Initiate antiviral therapy (IV if immunocompromised, oral if immunocompetent)
4. If chest pain is pleuritic or positional: Consider echocardiogram to evaluate for VZV-associated pericarditis
5. Pain management: Opioids for severe acute pain + early gabapentin/pregabalin or TCA if high risk for PHN
6. Follow-up: Monitor for postherpetic neuralgia development beyond 30 days after rash healing 6